skip to content

Cambridge Global Challenges

 

Organisations can apply to develop innovations that address the challenges of antimicrobial resistance (AMR) in humans.

This is a Small Business Research Initiative (SBRI) competition to address antimicrobial resistance (AMR). The Department of Health and Social Care (DHSC) will invest up to £10 million in 2 simultaneous competition strands.

Strand 1 projects must explore the scientific and technical feasibility of innovative solutions through proof of concept studies. They must focus on infection prevention and the development of new therapies and vaccines in relation to AMR.

Strand 2 projects should be technically more advanced and can include:

  • proof of concept in a model system
  • progression of a technical evaluation to the point of readiness for clinical testing
  • demonstration of effectiveness in humans, patients or the relevant environment

Eligibility

To lead a project, you can: be a business , academic institution or research organisation (RO); work alone or with others from business, the research base or the third sector as subcontractors.

Level of funding

  • Strand 1 projects to last up to 12 months and have total project costs of up to £500,000 including VAT.
  • Strand 2 projects to last between 12 and 24 months and total project costs of up to £2 million including VAT. All projects must start 1 January 2019.

 

For further details please see the GOV.UK Innovation Funding Service website.

Welcome to Cambridge Global Challenges

Cambridge Global Challenges is the Strategic Research Initiative of the University of Cambridge that aims to enhance the contribution of its research towards addressing the Sustainable Development Goals (SDGs) by 2030, with a particular focus on the poorer half of the world’s population.

 

Join the Strategic Research Initiative

Register to Cambridge Global Challenges here.

 

Contact us

Programme Manager (Sara Serradas Duarte): coordinator@gci.cam.ac.uk​